CYP-006TK Demonstrates Safety and Efficacy in DFU Clinical Trial
MELBOURNE, Australia, Dec. 5, 2024 /PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, has successfully completed its Phase 1 clinical trial...
Hisense Ranks Global No.2 in Q3 2024 High-End TV Market
QINGDAO, China, Dec. 2, 2024 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, is reaping the rewards of its premium TV strategy, ranking second with a third-quarter global high-end TV market share of 24%...
Global Focus INC-5 Conference: Niutech Demonstrates 10,000-ton Continuous Plastic Pyrolysis Technology and Complete Equipment
JINAN, China, Dec. 2, 2024 /PRNewswire/ -- From November 25th to December 1st, 2024, the fifth session of the Intergovernmental Negotiating Committee on Plastic Pollution (INC-5) has been held in the Busan Exhibition & Convention Center in South...
Motiff Demonstrates Superior Performance of MLLM in Evaluation Study
SAN JOSE, Calif., Nov. 27, 2024 /PRNewswire/ -- Motiff Technologies announced the successful development of MLLM by Motiff, a specialized multimodal large language model designed to revolutionize user interface (UI) design. This innovative AI model...
LifeSignals Receives FDA 510(k) Approval for UbiqVue™ 2A Multiparameter System
Cloud-Based System, Featuring Wearable Biosensor with Chest-Based SpO2, Enables Active Patient Monitoring Across Hospital and Out-of-hospital Care Settings Replaces time-consuming manual spot checking with continuous, near real-time active patient...
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
Launch of new application enables global access to highly recognized solid tumor profiling assay BOSTON and ROLLE, Switzerland, Nov. 21, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven...
CABIO Deepens Commitment to Global Markets, Aiming to Serve International Clients and Pursue Long-Term International Partnerships
FRANKFURT, Germany, Nov. 20, 2024 /PRNewswire/ -- CABIO, a high-tech enterprise underpinned by biotechnology and listed on the Science and Technology Innovation Board (stock code: 688089), unveiled its innovative product, NeoHMOs®, at the Food...